Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jolie Siegel currently holds 10,500 shares of C4 Therapeutics, Inc. (CCCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jolie Siegel has been a net seller of CCCC stock. They have purchased $0 and sold $1.2M worth of shares.
Jolie Siegel's most recent insider trade was on Nov 7, 2024, when they sold 3,750 shares at $0.00 per share.
Jolie Siegel serves as Executive at C4 Therapeutics, Inc. (CCCC). They have executed 28 insider transactions totaling $1.2M over their tenure at the company.
Jolie Siegel holds the position of Executive at C4 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Jolie Siegel has shown a selling trading pattern, with $0 in total purchases and $1.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jolie Siegel was on Sep 10, 2021, when they sold $625.0K worth of CCCC shares. This transaction involved 12,500 shares at $50.00 per share.
Jolie Siegel currently owns 10,500 shares of C4 Therapeutics, Inc. (CCCC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jolie Siegel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jolie Siegel has 28 Form 4 filings on record as an insider at C4 Therapeutics, Inc..
Set alerts for Jolie Siegel and 40,000+ other insiders.